Q11.2

Clinical Causes: Genetic mutations or inherited conditions Chromosomal abnormalities Environmental factors during fetal development, such as infections or exposure to teratogens Developmental disruptions in early pregnancy that affect eye formation Associated syndromes such as anophthalmia-microphthalmia complex

Key Symptoms: Reduced eye size noticeable at or shortly after birth Possible structural abnormalities like cryptophthalmos (hidden or fused eyelids) Limited vision or visual impairment depending on severity Asymmetry if only one eye is affected Associated abnormalities in other ocular structures or systemic organs

Diagnosis Path: Diagnosis of microphthalmos involves a detailed eye examination, possibly including imaging studies such as ultrasound, MRI, or CT scans. These assessments help determine the size, structure, and any associated ocular anomalies. Genetic testing may also be recommended to identify underlying mutations or syndromes. A thorough prenatal history and physical examination assist in understanding potential causes and associated conditions.

Treatment Protocols: Management of microphthalmos depends on the severity and associated conditions. Options may include: - Optical correction with glasses or contact lenses to optimize residual vision - Surgical procedures to correct structural anomalies or improve appearance - Use of prosthetic eyes when necessary to assist with cosmesis - Visual rehabilitation and low vision aids - Multidisciplinary care involving ophthalmologists, geneticists, and pediatric specialists to address associated anomalies Early intervention and tailored treatment plans are vital in supporting visual development and quality of life for affected individuals.